• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCF 介导的 Brg1 降解抑制胃癌转移。

SCF-mediated degradation of Brg1 suppresses gastric cancer metastasis.

机构信息

Key Laboratory of Systems Biomedicine (Ministry of Education) and Collaborative Innovation Center of Systems Biomedicine, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 800 Dong Chuan Road, 200240, Shanghai, China.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

出版信息

Nat Commun. 2018 Sep 3;9(1):3569. doi: 10.1038/s41467-018-06038-y.

DOI:10.1038/s41467-018-06038-y
PMID:30177679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6120942/
Abstract

Brg1/SMARCA4 serves as the ATPase and the helicase catalytic subunit for the multi-component SWI/SNF chromatin remodeling complex, which plays a pivotal role in governing chromatin structure and gene transcription. However, the upstream signaling pathways regulating Brg1 protein stability and its physiological contribution to carcinogenesis remain largely elusive. Here we report that Brg1 is a bona fide ubiquitin substrate of SCF. We reveal that CK1δ phosphorylates Brg1 at Ser31/Ser35 residues to facilitate the binding of Brg1 to FBW7, leading to ubiquitination-mediated degradation. In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples. Mechanistically, we find that stabilization of Brg1 in gastric cancer cells suppresses E-cadherin expression, subsequently promoting gastric cancer metastasis. Hence, this previously unknown FBW7/Brg1 signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric cancers.

摘要

Brg1/SMARCA4 作为多亚基 SWI/SNF 染色质重塑复合物的 ATP 酶和解旋酶催化亚基,在调节染色质结构和基因转录中起着关键作用。然而,调节 Brg1 蛋白稳定性及其对肿瘤发生的生理贡献的上游信号通路在很大程度上仍未被揭示。在这里,我们报告 Brg1 是 SCF 的真正泛素底物。我们揭示 CK1δ 在 Ser31/Ser35 残基处磷酸化 Brg1,以促进 Brg1 与 FBW7 的结合,导致泛素介导的降解。与 FBW7 在人类胃癌中作为肿瘤抑制因子的作用一致,我们在人类胃癌临床样本中发现 FBW7 和 Brg1 表达之间呈负相关。在机制上,我们发现胃癌细胞中 Brg1 的稳定会抑制 E-钙黏蛋白的表达,从而促进胃癌转移。因此,这个以前未知的 FBW7/Brg1 信号通路为靶向 FBW7 缺陷型人类胃癌中的 Brg1 提供了分子基础和理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/1b796fdac044/41467_2018_6038_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/2f5c60478671/41467_2018_6038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/76bce620834e/41467_2018_6038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/d3f868657a18/41467_2018_6038_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/00692aead9c2/41467_2018_6038_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/e92a090bcbb4/41467_2018_6038_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/1b796fdac044/41467_2018_6038_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/2f5c60478671/41467_2018_6038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/76bce620834e/41467_2018_6038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/d3f868657a18/41467_2018_6038_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/00692aead9c2/41467_2018_6038_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/e92a090bcbb4/41467_2018_6038_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6e/6120942/1b796fdac044/41467_2018_6038_Fig6_HTML.jpg

相似文献

1
SCF-mediated degradation of Brg1 suppresses gastric cancer metastasis.SCF 介导的 Brg1 降解抑制胃癌转移。
Nat Commun. 2018 Sep 3;9(1):3569. doi: 10.1038/s41467-018-06038-y.
2
FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation.FBW7通过调节FAAP20的降解来调控DNA链间交联修复。
Oncotarget. 2016 Jun 14;7(24):35724-35740. doi: 10.18632/oncotarget.9595.
3
Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer.FIRΔexon2在胃癌中对BRG1的转录后调控
Oncogenesis. 2020 Feb 18;9(2):26. doi: 10.1038/s41389-020-0205-4.
4
Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas.SWI/SNF复合物的组成成分BRG1的表达增加而非基因改变与人类胃癌的进展期相关。
Pathobiology. 2001;69(6):315-20. doi: 10.1159/000064638.
5
FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.FBW7 缺失通过稳定 Snail 蛋白促进非小细胞肺癌中的上皮间质转化。
Cancer Lett. 2018 Apr 10;419:75-83. doi: 10.1016/j.canlet.2018.01.047. Epub 2018 Jan 31.
6
FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.FBW7 通过抑制 HIF1α/CEACAM5 功能轴抑制结直肠癌的转移。
Int J Biol Sci. 2018 May 12;14(7):726-735. doi: 10.7150/ijbs.24505. eCollection 2018.
7
Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.染色质重塑因子BRG1/SMARCA4在人类癌症中的作用。
Epigenetics. 2008 Mar-Apr;3(2):64-8. doi: 10.4161/epi.3.2.6153. Epub 2008 Apr 17.
8
Physiological functions of FBW7 in cancer and metabolism.FBW7 在癌症和代谢中的生理功能。
Cell Signal. 2018 Jun;46:15-22. doi: 10.1016/j.cellsig.2018.02.009. Epub 2018 Feb 21.
9
ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.ZEB1 通过招募 SWI/SNF 染色质重塑蛋白 BRG1 来抑制 E-钙黏蛋白并诱导 EMT。
Oncogene. 2010 Jun 17;29(24):3490-500. doi: 10.1038/onc.2010.102. Epub 2010 Apr 26.
10
BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.靶向BRG1的STAT3/VEGFC信号通路调控结直肠癌中的淋巴管生成。
Oncotarget. 2016 Jun 14;7(24):36501-36509. doi: 10.18632/oncotarget.9038.

引用本文的文献

1
Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor.异常的PJA2-CHRM3信号传导在胃肿瘤中产生了一个治疗弱点。
Br J Cancer. 2025 Aug 26. doi: 10.1038/s41416-025-03145-8.
2
FOXP2 suppresses gastric cancer progression by transcriptionally repressing FBXW2 via WASL degradation.FOXP2通过WASL降解转录抑制FBXW2,从而抑制胃癌进展。
Cell Death Discov. 2025 Jul 28;11(1):348. doi: 10.1038/s41420-025-02643-1.
3
Epigenetic regulators in cancer therapy and progression.癌症治疗与进展中的表观遗传调控因子

本文引用的文献

1
FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.FBW7 缺失通过稳定 Snail 蛋白促进非小细胞肺癌中的上皮间质转化。
Cancer Lett. 2018 Apr 10;419:75-83. doi: 10.1016/j.canlet.2018.01.047. Epub 2018 Jan 31.
2
Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.肝细胞癌基因组和转录组分析确定了转化生长因子-β信号通路中的突变和基因表达变化。
Gastroenterology. 2018 Jan;154(1):195-210. doi: 10.1053/j.gastro.2017.09.007. Epub 2017 Sep 15.
3
NPJ Precis Oncol. 2025 Jun 28;9(1):206. doi: 10.1038/s41698-025-01003-7.
4
The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma.SMARCA4缺陷在早期肺大细胞癌中的预后意义
Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17541-0.
5
Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer.泛素蛋白酶体系统(UPS):癌症表观遗传格局的关键决定因素。
Epigenomics. 2025 Jun;17(9):625-644. doi: 10.1080/17501911.2025.2501524. Epub 2025 May 8.
6
PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer.PRMT5介导的精氨酸甲基化可稳定谷胱甘肽过氧化物酶4(GPX4)以抑制癌症中的铁死亡。
Nat Cell Biol. 2025 Apr;27(4):641-653. doi: 10.1038/s41556-025-01610-3. Epub 2025 Mar 3.
7
FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects.FBXW7在胃肠道癌症中的研究:从分子机制到治疗前景
Front Pharmacol. 2024 Dec 18;15:1505027. doi: 10.3389/fphar.2024.1505027. eCollection 2024.
8
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma.靶向酪蛋白激酶 1δ抑制致癌 NRAS 驱动的黑色素瘤。
Nat Commun. 2024 Nov 21;15(1):10088. doi: 10.1038/s41467-024-54140-1.
9
PRMT1-mediated methylation of ME2 promotes hepatocellular carcinoma growth by inhibiting ubiquitination.PRMT1 介导的 ME2 甲基化通过抑制泛素化促进肝癌生长。
Cell Death Dis. 2024 Nov 11;15(11):814. doi: 10.1038/s41419-024-07219-y.
10
Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC.胆固醇抑制肝癌中AMFR介导的PDL1泛素化和降解。
Mol Cell Biochem. 2025 Mar;480(3):1807-1818. doi: 10.1007/s11010-024-05106-w. Epub 2024 Sep 4.
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation.
BRG1染色质重塑酶将癌细胞代谢与增殖联系起来。
Oncotarget. 2016 Jun 21;7(25):38270-38281. doi: 10.18632/oncotarget.9505.
4
Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells.靶向染色质重塑酶BRG1可提高化疗药物对乳腺癌细胞的疗效。
Oncotarget. 2016 May 10;7(19):27158-75. doi: 10.18632/oncotarget.8384.
5
BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways.BRG1/SMARCA4通过调节细胞死亡和生存途径对神经母细胞瘤细胞的生存至关重要。
Oncogene. 2016 Sep 29;35(39):5179-90. doi: 10.1038/onc.2016.50. Epub 2016 Mar 21.
6
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.选择性靶向 BRG/PB1 溴结构域会损害胚胎和滋养层干细胞的维持。
Sci Adv. 2015 Nov 13;1(10):e1500723. doi: 10.1126/sciadv.1500723. eCollection 2015 Nov.
7
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer.SMARCA4/BRG1是一种新型预后生物标志物,可预测切除的非小细胞肺癌中基于顺铂化疗的结果。
Clin Cancer Res. 2016 May 15;22(10):2396-404. doi: 10.1158/1078-0432.CCR-15-1468. Epub 2015 Dec 15.
8
Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.Brg1在胰腺癌形成的不同阶段既促进肿瘤抑制活性,也促进致癌活性。
Genes Dev. 2015 Mar 15;29(6):658-71. doi: 10.1101/gad.256628.114.
9
Gastric cancer review.胃癌综述。
J Carcinog. 2014 Dec 19;13:14. doi: 10.4103/1477-3163.146506. eCollection 2014.
10
COSMIC: exploring the world's knowledge of somatic mutations in human cancer.COSMIC:探索全球关于人类癌症体细胞突变的知识。
Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11. doi: 10.1093/nar/gku1075. Epub 2014 Oct 29.